About Treysta Medical Technologies
Treysta Medical Technologies is a private company based in Gainesille, Florida, incorporated in 2025 in Delaware. It has reported $182,500 raised in two offerings on Form D since April 2025. Its chief executive is Nathan Zarnstorff.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 19, 2026 | Feb 17, 2026 | $90,000of $300K target | 5 | $18,000 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Apr 4, 2025 | Apr 10, 2025 | $92,500of $150K target | 5 | $18,500 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Total, two offerings | $182,500 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Treysta Medical Technologies's Form D filed Feb 17, 2026.
NZ
Nathan Zarnstorff
President and CEO, director
MB
Marcelo Buzzi
Executive officer and director